Elisei R, Wirth LJ, Capdevila J, Hoff AO, et al. Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer. Thyroid 2025 Aug 18. doi: 10.1177/10507256251367352.
PMID: 40828665